Quote:

---

“After the sixth, seventh treatment we really saw it breaking down the blood-brain barrier.”

---

Not leronlimab. It's a drug that opens the blood brain barrier so other cancer drugs can cross to the brain. The problems I can see are that it allows opportunistic infections to cross to the brain and could also allow greater metastasis of cancer cells to the brain. It may help but not a great option.